longitudinal (-16.1±2.8% vs -21.7±2.2%, p<0.001), 4-chamber LV longitudinal strain (-15±2.8% vs -22.3±1.6%, p<0.001), 2-chamber LV longitudinal strain (-15.8±3.2% vs -20±1.4%, p<0.001) and overall global LV longitudinal strain (-14.4±2.5% vs -21.7±1.4%, p<0.0001). Circumferential LV strain was preserved in patients compared to controls ( -21.7±5.4% vs -23.3±2.7%, p=0.5).
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Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience Emmanuelle Vermes (1), Julien Pucheux (1), Anne Delhommais (1), Alain Mirza (2), Laurent Brunereau (1) (1) CHU Trousseau, Radiologie, Chambray Les Tours, CHU Trousseau, Chirurgie cardiaque, Chambray Les Tours, France Background: Antibody-mediated rejection (AMR) is characterized by histopathological and immunophenotypic findings such as activated endothelial cells, intravascular macrophages and evidence of capillary C4d deposition. This inflammatory reaction could be followed by diffuse fibrosis. Cardiac magnetic resonance (CMR) with recently T1 mapping is a promising technique to identify diffuse myocardial fibrosis. The purpose of this study was to assess T1 mapping in patients with AMR.
Method: 2 patients with clinical AMR (histopathological and immunophenotypic findings, presence of donor-specific allo antibodies and allograft dysfunction) performed a CMR study one week (for the first patient) and 3 weeks (for the second patient) after the treatment of AMR (plasmapheresis, IV Immunoglobulins and Rituximab). Images were acquired on a 1.5 Tesla scanner (Siemens) including T1 mapping using a shortened modified looklocker inversion-recovery sequence and T2 mapping in a matched mid-ventricular short axis slice using a black-blood single shot fast spin echo pulse sequence. Segmental and global T1 values were measured before and 15 minutes after administration of 0.2 mmol/kg of Gadoteric acid and compared to our cohort of 17 controls.
Results: Mean non contrast T1 values were significantly higher in heart transplants patients compared to controls (1100±5ms vs 947±29ms, P <0.001). Segmental T1 values were significantly higher in the 6 regions of interest compared to controls (P <0.001 in all segments). Mean post contrast T1 values were not significantly different in patients and controls. Mean T2 value was higher in patients compared to controls (73±13 vs 50± 4ms), suggesting the presence of global edema.
Conclusion:
Heart transplant patients with clinical antibody-mediated rejection show a significant increased global and segmental non contrast T1 values suggesting the presence of diffuse myocardial fibrosis. Further studies are required to confirm these data.
Surgical aortic valve replacement in patients with small aortic annulus using a new rapid deployment bioprosthesis: preliminary results
Alexis Theron, Vlad Gariboldi, Dominique Grisoli, Pierre Morera, Nicolas Jaussaud, Severine Leroux, Amanatiou Cecile, Alberto Riberi, Frederic Collart CHU La Timone-APHM, Chirurgie cardiaque, Marseille, France Background: optimal management of patient with small aortic annulus who require aortic valve replacement (AVR) is debated. The adverse prognostic impact of a prosthesis -patient mismatch (PPM) is well established. Hemodynamic performance of new generation of rapid deployment aortic bioprosthesis with LVOT enlargement by the sub-valvular expandable frame must be evaluated.
Objectives: to determine the prelimary results (1month FU) in patients operated on aortic stenosis with Edwards INTUITY bioprosthesis.
Methods: Inclusion criteria: 1/Severe symptomatic aortic stenosis 2/ Small aortic annulus 3/ tricuspid aortic valve. Endpoints: 1/ Success of procedure and in-hospital mortality 2/ post op evolution of mean gradient and indexed effective orifice area (iEOA) 3/Evolution of LV mass 4/Incidence of periprosthetic regurgitation (PPR) 5/incidence of PPM.
Results: 38 patients, age = 78.6±6.6, BMI = 25.5± 3.3, Euroscore II= 3. 
